diquafosol tetrasodium ophthalmic solution, 2%
Sponsors
Merck Sharp & Dohme LLC
Conditions
Dry Eye Disease
Phase 3
Study of Diquafosol Tetrasodium Ophthalmic Solution in Subjects With Dry Eye Disease
CompletedNCT00403975
Start: 2004-06-30End: 2004-11-30Updated: 2016-02-22
Study of the Effect of Diquafosol Tetrasodium Ophthalmic Solution, 2% Versus Placebo in Dry Eye Subjects (P08634)
CompletedNCT00600288
Start: 2008-01-31End: 2008-05-31Updated: 2015-01-09
The Effects of Diquafosol Tetrasodium Ophthalmic Solution, 2% in Subjects With Dry Eye Disease (P08637)
CompletedNCT00831662
Start: 2009-01-31End: 2009-12-31Updated: 2015-01-09